Morepen Laboratories logo

Morepen Laboratories financials and balance sheet

NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap

Last close ₹123.54up ₹5.87 (4.99%)BSE ₹123.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹117.67.

52-week range of traded prices to 23 Oct 2026
₹33.05Low, 30 Mar 2026₹150.70High, 7 Oct 2026
Market cap
₹6,769 Cr1,108th largest listed
P/E
48.2
P/E without one-offs
59.0
P/B
5.4
Dividend yield
0.16%
ROE
11.7%
ROE without one-offs
9.5%
ROCE
10.3%
Debt to equity
0.16
Volume, NSE
50,63,581

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Morepen Laboratories annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹1,812 Cr, year to Mar 2025

Operating and net margin, per cent

  • Operating margin
  • Net margin

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 14.8% of operating profit in the first full year.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue1,806
  2. Materials and goods−1,123
  3. Employee costs−233
  4. Other expenses−324
  5. Operating profit126
  6. Depreciation−36
  7. Other income+21
  8. One-off items+26
  9. Finance costs−16
  10. Profit before tax120
  11. Tax−24
  12. Joint ventures−0.8
  13. Net profit95

What the company owns

  • Plant, investments and other assets₹1,239 Cr
  • Receivables₹333 Cr
  • Inventory₹272 Cr
  • Cash and bank₹69 Cr
  • Current investments₹23 Cr

What pays for it: net worth and liabilities

  • Net worth₹1,247 Cr
  • Owed to suppliers₹317 Cr
  • Borrowings₹195 Cr
  • Other liabilities₹177 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Morepen Laboratories quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 5 MayMar 2020Filed 22 JunMar 2021Filed 5 MayMar 2022Filed 6 MayMar 2023Filed 17 MayMar 2024Filed 22 MayMar 2025Filed 10 JunMar 2026Filed 26 May
Revenue from operations5846077698531,1881,5471,4181,6901,8121,806
5235427017851,0701,4101,3381,5321,6381,680
Materials and goods bought3633694965577811,0499561,0621,1591,123
Employee costs––95110136164155181209233
Other expenses––109117153197228288269324
Operating profit before depreciation6165686911913780159174126
Operating margin10.4%10.7%8.8%8.0%10.0%8.8%5.6%9.4%9.6%7.0%
Materials, % of revenue––64.6%65.3%65.7%67.8%67.4%62.8%64.0%62.2%
Employee costs, % of revenue––12.4%12.9%11.4%10.6%10.9%10.7%11.5%12.9%
Other expenses, % of revenue––14.2%13.7%12.9%12.7%16.1%17.0%14.9%17.9%
Depreciation and amortisation34344037302828332936
Operating profit after depreciation27302832881095212514589
Other income444912106141821
Finance costs74222−724816
Profit before one-off items and tax24302939991275613515594
One-off items00000000026
Profit before tax243029399912756135155120
000612517393724
Share of profit of joint ventures and associates––0000000−1
Net profit2430293497102399611895
Other comprehensive income––−2−300−1−206
Total comprehensive income––2731971013794118101
Net margin4.0%4.9%3.8%3.9%8.2%6.6%2.7%5.7%6.5%5.3%
Net margin without joint ventures and associates––3.8%3.9%8.2%6.6%2.7%5.7%6.5%5.3%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 5 MayMar 2020Filed 22 JunMar 2021Filed 5 MayMar 2022Filed 6 MayMar 2023Filed 17 MayMar 2024Filed 22 MayMar 2025Filed 10 JunMar 2026Filed 26 May
2532844245787528471,1871,247
2532844255797538471,1561,246
Share capital90909096102102110110
Reserves1631943354836517451,0471,137
Belonging to outside owners of subsidiaries000000311
11121619252979195
339351404456321402501490
23283035374490199
Total assets6156638581,0701,1101,2931,7781,936
316291331336354404619773
2993725277347568891,1591,164
Net debt−21−27−52−27−31−23−48103
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 5 MayMar 2022Filed 6 MayMar 2023Filed 17 MayMar 2024Filed 22 MayMar 2025Filed 10 JunMar 2026Filed 26 May
51−58−91733233
52−33−751116958
−78−182−160−61−123−114
Receivables−44−69−13−620−50
Inventories−37−10147−20−5118
Payables00000−25
Other working capital3−13−19521−72−57
Tax paid−1−25−17−38−37−25
Capital spending2245367112486
Free cash flow29−103−1272−92−53
−70−32−47−83−322−123
4764144530097
Dividends paid0000011
Shares bought back000000
Shares issued05313701910
Net change in cash28−266−5107
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Morepen Laboratories dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 5 MayMar 2020Filed 22 JunMar 2021Filed 5 MayMar 2022Filed 6 MayMar 2023Filed 17 MayMar 2024Filed 22 MayMar 2025Filed 10 JunMar 2026Filed 26 May
Earnings per share₹0.51₹0.66₹0.64₹0.75₹2.16₹2.26₹0.77₹1.88₹2.20₹1.73
Diluted earnings per share₹0.51₹0.66₹0.64₹0.75₹2.15₹1.96₹0.77₹1.88₹2.20₹1.73
Dividend per share––––––––₹0.20₹0.20
Book value per share––₹5.63₹6.32₹9.44₹12.11₹14.73₹16.58₹21.10₹22.75
Dividend payout––––––––9.3%11.6%
Shareholder yield––––0.0%−3.2%−10.4%0.0%−7.3%0.6%
Market cap at the year end (₹ crore)8551,3857764301,4441,6441,3192,1492,6211,846

Ratios

Consolidated, years to March.Morepen Laboratories PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 5 MayMar 2020Filed 22 JunMar 2021Filed 5 MayMar 2022Filed 6 MayMar 2023Filed 17 MayMar 2024Filed 22 MayMar 2025Filed 10 JunMar 2026Filed 26 May
Revenue growth–3.9%26.7%11.0%39.3%30.2%−8.4%19.3%7.2%−0.3%
Operating profit growth–6.3%4.3%1.5%73.0%15.3%−41.8%99.4%9.7%−27.8%
Net profit growth–25.7%−2.5%16.4%189.1%4.7%−62.0%148.6%22.7%−19.6%
Earnings per share growth–29.4%−3.0%17.2%188.0%4.6%−65.9%144.2%17.0%−21.4%
––11.4%12.5%27.4%20.3%5.8%12.0%11.8%7.9%
–––1.1 pts14.9 pts−7.1 pts−14.5 pts6.2 pts−0.2 pts−3.9 pts
From the net margin–––0.6 pts13.5 pts−5.4 pts−11.9 pts6.3 pts1.7 pts−2.3 pts
From asset turnover–––0.8 pts4.4 pts0.6 pts−1.6 pts1.0 pts−2.2 pts−1.7 pts
From borrowing–––−0.3 pts−3.0 pts−2.4 pts−1.0 pts−1.1 pts0.2 pts0.1 pts
Return on capital employed––10.5%10.7%20.0%18.3%6.6%14.3%11.5%6.2%
Cash conversion––––52.5%−56.8%−235.7%76.3%27.2%34.4%
Interest cover3.87.013.115.949.3−14.826.133.717.45.4
Debt to equity––0.040.040.040.030.030.030.070.16
Receivable days––6459565968706567
Inventory days––6991829687859488
Payable days––124113989087101114103
Cash conversion cycle, days––937406569544553
Working capital days––−30−3225910499118130
Asset turnover––1.251.331.561.601.301.411.180.97
Assets per rupee of net worth––2.432.382.151.921.641.501.531.55
Sales per rupee of plant––5.226.369.1910.558.497.935.724.74
Capital spending to depreciation––––0.721.641.282.134.282.35
Plant being built, % of plant in use––0.0%0.0%1.5%9.6%10.2%11.5%9.0%5.7%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
5.1%
Cash from operations against operating profit
26.0%
Measure10 years5 years3 years
Revenue growth, yearly rate–8.7%8.4%
Profit growth, yearly rate–−0.5%34.9%
Return on equity, average–11.6%10.6%
Return on capital employed, average–11.4%10.6%
Operating margin, average8.8%8.1%8.7%
Net margin, average5.2%5.4%5.8%
Asset turnover, average–1.291.19
Cash conversion cycle, days, average–5751
Interest cover, average15.713.618.9
Debt to equity, average–0.060.09

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−1113833
Cash from investing−606−528−123
Cash from financing61040297
Capital spending36228186
Dividends paid111111
Shares bought back000
Shares issued for cash3801910
Borrowings raised193186132
Borrowings repaid181616

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––734645
Altman Z-scorePublished threshold 1.81––3.002.624.494.894.955.815.254.01
Beneish M-scorePublished threshold −1.78––––−1.86−1.46−1.82−2.33−2.10−2.43
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––15.3119.8216.188.8326.5310.00
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––−0.41−0.320.060.45
Receivables growth less revenue growthOur threshold 0 percentage points–––−8.06−7.097.5313.394.18−7.222.90
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––34.73−13.4222.90−8.11−2.5511.55−6.28
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––2.103.753.893.243.307.943.30
Assets under construction, years of additionsOur threshold 2 years of additions–––0.000.080.310.350.310.210.21
Effective tax ratePublished threshold 17.16 per cent0.000.001.1514.141.4419.7530.6328.6523.9120.24
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––0.070.940.50−0.04−0.84
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
22 Aug 2025Infomerics Valuation and Ratings Private Limited (opens in a new tab)Long Term Bank FacilitiesIVR A-New, NewStable225
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.